GLP-1 Drug Market Size, Share, Growth Drivers, Trends, Opportunities
February 16, 2024 ⚊ 1 Min read ⚊ Views 25 ⚊ BUSINESSGene Therapy in Cardiovascular Disorder Market was valued at US$ 178 million in 2023 and is anticipated to reach US$ 1351.3 million by 2030, witnessing a CAGR of 21.1% during the forecast period 2024-2030. The growth of the market is driven by the increasing prevalence of cardiovascular diseases, the rising demand for minimally invasive procedures.
Tags: cardiovascular disorders, Gene therapy, heart dise